| Patients in England to be first in Europe to access immunotherapy to stall cancer progress Related items from OnMedica Study shows huge global variation in cancer drug costs Meeting cancer promises and more – a new model for NHS diagnostics? Ten year hormonal therapy cuts breast cancer relapse Cancer treatment good but aftercare less so Put case for adding leukaemia drug to Cancer Drugs Fund, NICE tells company |
Friday, 17 June 2016
NICE fast-tracks approval of new skin cancer treatment
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment